Literature DB >> 4213284

Pancreatic ribonuclease: enzymic and physiological properties of a cross-linked dimer.

J Bartholeyns, S Moore.   

Abstract

Monomeric ribonuclease A has very low activity toward typically double-stranded RNA's; the dimeric form of ribonuclease A obtained by cross linking the enzyme by dimethyl suberimidate has more than 78 times the activity of the monomer toward polyadenylate . polyuridylate and 440 times the activity of the monomer toward the double-stranded RNA of a virus from Penicillium chrysogenum. The half-life of the dimer in the bloodstream of the rat is 12 times that of the mononmer.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4213284     DOI: 10.1126/science.186.4162.444

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Inhibition of tumor cell proliferation by dimerized ribonuclease.

Authors:  J Bartholeyns; P Baudhuin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

2.  The activity on double-stranded RNA of aggregates of ribonuclease A higher than dimers increases as a function of the size of the aggregates.

Authors:  M Libonati; M Bertoldi; S Sorrentino
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

3.  The molecular evolution of pancreatic ribonuclease.

Authors:  J J Beintema; W Gaastra; J A Lenstra; G W Welling; W M Fitch
Journal:  J Mol Evol       Date:  1977-09-20       Impact factor: 2.395

4.  Inhibition of the discharge of endocytosed protein from phagosomes into lysosomes in hepatoma cells exposed to dimerized ribonuclease A.

Authors:  J Bartholeyns; J Quintart; P Baudhuin
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

5.  Antitumor activity of ribonuclease multimers created by site-specific covalent tethering.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Christine I Schilling; Ronald T Raines
Journal:  Bioconjug Chem       Date:  2010-09-15       Impact factor: 4.774

Review 6.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 7.  Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

Authors:  Khaled Greish; Jun Fang; Takao Inutsuka; Akinori Nagamitsu; Hiroshi Maeda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Susceptibility of murine transfer factor to dimerized ribonuclease A.

Authors:  D Rifkind; J A Frey; M Dinowitz
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

Review 9.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.